Oramed Pharmaceuticals Inc
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. Show More...
-
Website https://www.oramed.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 2.13 USD
-
Last Updated 14-07-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-08 2011-08 2012-08 2013-08 2014-08 2015-08 2016-08 2017-08 2018-08 2019-08 TTM Earnings Per Share USD -0.6 -0.29 -0.57 -0.59 -0.62 -0.67 -0.87 -0.79 -0.86 -0.82 -0.71 Dividends USD Payout Ratio % * Shares Mil 5.0 5.0 6.0 7.0 9.0 11.0 13.0 13.0 15.0 17.0 18.0 Book Value Per Share * USD 0.17 0.64 0.57 0.52 2.17 1.84 2.35 1.45 0.95 1.24 0.69 Free Cash Flow Per Share * USD -0.3 -0.3 -0.39 -0.51 -0.41 -0.45 -0.26 0.23 -0.85 -0.83 Return on Assets % -126.35 -54.05 -69.53 -60.65 -37.4 -30.04 -31.7 -25.7 -29.56 -34.99 -35.1 Financial Leverage (Average) 1.75 1.16 1.4 1.07 1.05 1.06 1.64 2.01 1.52 1.79 1.86 Return on Equity % -166.5 -68.56 -89.16 -71.07 -39.39 -31.7 -42.98 -46.14 -50.55 -56.85 -60.73 Return on Invested Capital % -166.87 -69.19 -85.94 -71.37 -40.35 -32.44 -44.1 -48.21 -54.14 -59.91 -64.63 Interest Coverage -202.69 -83.41 -15.34 -516.45 Current Ratio 3.05 9.71 8.19 17.35 22.38 11.67 8.62 3.93 6.82 6.28 5.72 Quick Ratio 2.99 5.59 7.32 6.61 3.31 3.56 1.87 1.32 2.11 1.32 2.26 Debt/Equity